Table 2. In vitro inhibition of TNF-α-induced NF-κB activation in the NCI-H460 lung adenocarcinoma cell line.

Compd.	IC50 (μM)	Compd.	IC50 (μM)
2Y1	>20	3Y9	15.51 ± 1.02
2Y2	>20	3Y10	7.13 ± 0.44
2Y4	15.96 ± 0.21	5Y1	14.83 ± 0.38
2Y5	8.04 ± 0.56	5Y2	10.14 ± 0.34
2Y10	10.32 ± 0.29	5Y3	4.80 ± 0.47
2Y11	16.24 ± 0.60	5Y4	3.64 ± 0.52
3Y1	>20	5Y5	2.26 ± 0.48
3Y2	>20	5Y8	0.36 ± 0.08
3Y3	15.17 ± 0.76	5Y9	4.80 ± 0.55
3Y4	>20	5Y10	2.33 ± 0.17
3Y5	5.43 ± 0.68	UA	>20
3Y8	0.94 ± 0.27